1. Home
  2. BIOX vs ALGS Comparison

BIOX vs ALGS Comparison

Compare BIOX & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bioceres Crop Solutions Corp.

BIOX

Bioceres Crop Solutions Corp.

HOLD

Current Price

$0.47

Market Cap

35.6M

Sector

Industrials

ML Signal

HOLD

Logo Aligos Therapeutics Inc.

ALGS

Aligos Therapeutics Inc.

HOLD

Current Price

$6.38

Market Cap

39.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIOX
ALGS
Founded
2001
2018
Country
Argentina
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.6M
39.9M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
BIOX
ALGS
Price
$0.47
$6.38
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$4.33
$39.33
AVG Volume (30 Days)
308.0K
220.9K
Earning Date
05-19-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
88.30
EPS
N/A
N/A
Revenue
N/A
$2,186,000.00
Revenue This Year
N/A
$32.20
Revenue Next Year
$37.82
$4.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.35
$5.12
52 Week High
$5.18
$13.69

Technical Indicators

Market Signals
Indicator
BIOX
ALGS
Relative Strength Index (RSI) 43.50 47.71
Support Level $0.42 $6.25
Resistance Level $0.68 $6.76
Average True Range (ATR) 0.05 0.47
MACD -0.00 0.03
Stochastic Oscillator 8.75 72.22

Price Performance

Historical Comparison
BIOX
ALGS

About BIOX Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

About ALGS Aligos Therapeutics Inc.

Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.

Share on Social Networks: